Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS) — VMCI valuation read

688578.SS screens at VMCI 51/100, a 1-point gap above the Healthcare sector median (50). For a mid-cap Shanghai Allist Pharmaceuticals Co., Ltd. share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

688578.SS has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 688578.SS trades at 26.0x earnings, 44% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 1.1x leaves covenant headroom, which sets the rate-cycle exposure for Shanghai Allist Pharmaceuticals Co., Ltd..

688578.SS rose 1.2% over the trailing 7 days, with a -13.4% read on a 30-day basis.